Compare International Business Machines Corp (IBM) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Business Machines Corp vs Kymera Therapeutics Inc. Common Stock — how do they compare? International Business Machines Corp trades at $228.74 (market cap $217.43B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: International Business Machines Corp is far larger — about 24.5× Kymera Therapeutics Inc. Common Stock's market cap, and International Business Machines Corp pays a 2.93% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 89 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| IBM | KYMR | |
|---|---|---|
Market Cap | $217.43B | $8.87B |
Volume | 5,119,486 | 779,107 |
Sector | Technology | Health |
52-Week High | $329.23 | $127.31 |
52-Week Low | $205.77 | $55.80 |
Typical Hold Time | 89 Days | 0 Days |
Enterprise Value | $274.57B | $8.26B |
Dividend Yield | 2.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBM trades at $227.88, up 0.38% with a bearish technical signal despite recent positive momentum. The company shows strong fundamentals with 2025 revenue of $67.54B and net income of $10.59B, representing a 15.52% margin. Recent earnings beat expectations in two of the last three quarters, while Q3 2026 results are pending. Analyst consensus is mixed with 47% buy ratings and a $255.50 price target, suggesting 12% upside potential from current levels.
IBM presents a balanced opportunity with solid profitability and AI consulting growth offset by cyclical mainframe weakness and negative cash flow trends. The stock's current valuation at 20.5x P/E appears reasonable given the company's pivot to high-margin hybrid cloud and AI services. Key risks include execution challenges in the AI transition and competitive pressures in the consulting space.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
